Gossamer Bio, Inc. Common Stock

$0.178
USD
Last updated on --.
24h volume6.69M
24h highest0.19100 USD
24h lowest0.17800 USD
24h Price movement-5.47%

GOSS recent prices

24 Hours
-5.47%-$0.0103
30 days
-46.32%-$0.1622
60 days
-45.65%-$0.1579
90 days
-62.47%-$0.3128

Key data

Previous close0.18830 USD
Market cap54.19M USD
Volume6.69M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.77000 USD
Net income (FY)-180.40M USD
Revenue (FY)55.54M USD
Last report dateMay 15, 2026

About Gossamer Bio, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
HeadquartersSAN DIEGO
Employees (FY)162.00
Revenue per employee (FY)342.82K USD
Net income per employee (FY)-1.11M USD
Listed onNasdaq
Official website

GOSS conversion tables

GOSSGOSS
USDUSD
0.5 GOSS0.089 USD
1 GOSS0.178 USD
5 GOSS0.89 USD
10 GOSS1.780 USD
USDUSD
GOSSGOSS
0.5 USD2.808 GOSS
1 USD5.617 GOSS
5 USD28.08 GOSS
10 USD56.17 GOSS

FAQ

GOSS is trading at $0.178, -5.47% over the last 24 hours. Track live moves on the price chart at the top of this page.
The GOSS stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. GOSS is currently trading at $0.178, -5.47% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on GOSS price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. GOSS's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from GOSS; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against GOSS's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Gossamer Bio, Inc. Common Stock's market cap is currently 54.19M USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume6.69M
24h highest0.19100 USD
24h lowest0.17800 USD
24h Price movement-5.47%
GOSSGOSS
USDUSD
Start trade with GOSS Perpetual